Brief: Vallon Pharmaceuticals Inc Provides Update On Recent Pipeline And Corporate Advancements
12/10/2021 13:39
Oct 12 (Reuters) - Vallon Pharmaceuticals Inc VLON.O :
* VALLON PHARMACEUTICALS PROVIDES UPDATE ON RECENT PIPELINE
AND
CORPORATE ADVANCEMENTS
* VALLON PHARMACEUTICALS INC - LEAD PROGRAM, ADAIR,
ADVANCING
TOWARD COMPLETION OF PATIENT ENROLLMENT AND TREATMENT IN ONGOING
SEAL STUDY
Source text for Eikon: ID:nGNX9hBHDX
Further company coverage: VLON.O
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027